www.emjreviews.com Open in urlscan Pro
2606:4700:20::681a:cac  Public Scan

Submitted URL: https://go.emjreviews.com/e3t/Ctc/OR+113/d2nlb104/VWn14L16rHtbW6V_bVq1QdzcJW8cYYgJ5pGwT5N28qGxb3lYMRW8wLKSR6lZ3l8T3vkj6DDC...
Effective URL: https://www.emjreviews.com/therapeutic-area/oncology/post/news/?page_from=1&page_to=3&utm_medium=email&_hsenc=p2ANqtz-8hSpN...
Submission: On December 17 via api from FR — Scanned from FR

Form analysis 2 forms found in the DOM

GET https://www.emjreviews.com

<form role="search" method="get" action="https://www.emjreviews.com" data-hs-cf-bound="true">
  <div class="input-button-wrapper">
    <input class="search-input" type="search" name="s" placeholder="Search" aria-label="Search the site">
    <button title="Search"><svg viewBox="0 0 19 19" fill="none" xmlns="http://www.w3.org/2000/svg">
        <path
          d="M17.9588 16.6012C18.3338 16.9762 18.3338 17.5837 17.9588 17.9587C17.5838 18.3337 16.9762 18.3337 16.6013 17.9587L11.9044 13.2637C11.7187 13.0762 11.3869 13.05 11.1769 13.1962C11.1769 13.1962 11.0456 13.2956 10.7681 13.455C9.71626 14.0568 8.49749 14.4 7.2 14.4C3.2231 14.4 0 11.1769 0 7.2C0 3.2231 3.2231 0 7.2 0C11.1769 0 14.4 3.2231 14.4 7.2C14.4 8.5069 14.0513 9.73311 13.4437 10.7888C13.2862 11.0606 13.2 11.1713 13.2 11.1713C13.0481 11.3888 13.0762 11.7188 13.2637 11.9044L17.9588 16.6012ZM7.20003 12.48C10.1156 12.48 12.48 10.1156 12.48 7.19998C12.48 4.28436 10.1156 1.91998 7.20003 1.91998C4.28441 1.91998 1.92003 4.28436 1.92003 7.19998C1.92003 10.1156 4.28441 12.48 7.20003 12.48Z"
          fill="currentColor"></path>
      </svg>
    </button>
  </div>
</form>

GET

<form method="GET" id="content-location-form"
  data-amj-url="https://www.emjreviews.com/en-us/amj/therapeutic-area/oncology/post/news/?page_from=1&amp;page_to=3&amp;utm_medium=email&amp;_hsenc=p2ANqtz-8hSpN0u6VHtjZsjnV8BdTfmK6tBQD_9wQW2a9WvWMe7NtVv-w15qCL8TPcbo7atyDNES4rnOoGSzitg9EOOxSqRggwH9tz3Olz5o1MeVE_zLaE5mI&amp;_hsmi=338742566&amp;utm_content=338730529&amp;utm_source=hs_email"
  data-emj-url="https://www.emjreviews.com/therapeutic-area/oncology/post/news/?page_from=1&amp;page_to=3&amp;utm_medium=email&amp;_hsenc=p2ANqtz-8hSpN0u6VHtjZsjnV8BdTfmK6tBQD_9wQW2a9WvWMe7NtVv-w15qCL8TPcbo7atyDNES4rnOoGSzitg9EOOxSqRggwH9tz3Olz5o1MeVE_zLaE5mI&amp;_hsmi=338742566&amp;utm_content=338730529&amp;utm_source=hs_email"
  data-hs-cf-bound="true">
  <label for="content-location-select">Edition</label>
  <select id="content-location-select" name="edition">
    <option selected="selected" value="european">European</option>
    <option value="us">US</option>
  </select>
</form>

Text Content

 * Therapy Area
   * Allergy & Immunology
   * Cardiology
   * Dermatology
   * Diabetes
   * Flagship Journal
   * Gastroenterology
   * General Healthcare
   * Hematology
   * Hepatology
   * Innovations
   * Interventional Cardiology
   * Microbiology & Infectious Diseases
   * Nephrology
   * Neurology
   * Oncology
   * Radiology
   * Reproductive Health
   * Respiratory
   * Rheumatology
   * Urology
 * Podcasts
 * Journals
 * Webinars
 * Collaborate
   * EMJ Media Pack
   * AMJ Media Pack
   * Editorial Enquiries
   * Contributors & Authors
   * Submit a Paper
   * Media Partners
   * Pharma Partners
   * EMJ Interactive
 * About
   * About
   * EQOH
   * Careers
   * Contact Us
 * EMJ Gold
 * search
 * Subscribe FREE

You must accept all conditions before being able to view the post
Continue
EUR USA
EUR
USA
 * Therapy Area
      
    * Allergy & Immunology
    * Cardiology
    * Dermatology
    * Diabetes
    * Flagship Journal
    * Gastroenterology
    * General Healthcare
    * Hematology
    * Hepatology
    * Innovations
    * Interventional Cardiology
    * Microbiology & Infectious Diseases
    * Nephrology
    * Neurology
    * Oncology
    * Radiology
    * Reproductive Health
    * Respiratory
    * Rheumatology
    * Urology

 * Podcasts
 * Journals
 * Webinars
 * Collaborate
      
    * EMJ Media Pack
    * AMJ Media Pack
    * Editorial Enquiries
    * Contributors & Authors
    * Submit a Paper
    * Media Partners
    * Pharma Partners
    * EMJ Interactive

 * About
      
    * About
    * EQOH
    * Careers
    * Contact Us

 * EMJ Gold
 * 
 * Subscribe FREE




Edition European US


ONCOLOGY

Filter
 * Journals
 * About
 * Congress reviews
 * Abstracts
 * Articles
 * Podcasts
 * Videos & Webinars
 * News
 * Infographics
 * Submit A Paper




NEW STUDY UNCOVERS ROLE OF MYO1F PROTEIN IN T-CELL METABOLISM AND CANCER


December 2024
Researchers have identified the protein MYO1F as a key regulator of T-cell
metabolism, with implications for immune responses, cancer, and autoimmune
diseases…
Read more
16 Dec 2024


NEW STUDY UNCOVERS ROLE OF MYO1F PROTEIN IN T-CELL METABOLISM AND CANCER

Researchers have identified the protein MYO1F as a key regulator of T-cell
metabolism, with implications for immune responses, cancer, and autoimmune
diseases…
14 Dec 2024


NEW MODEL IMPROVES PROGNOSIS FOR MERKEL CELL CARCINOMA

A recent study has shed light on improving the prognostication of Merkel cell
carcinoma, a rare and aggressive form of skin cancer.

12 Dec 2024


HIGHER FAECAL HAEMOGLOBIN LINKED TO COLORECTAL CANCER RISK

A new systematic review and meta-analysis highlights a significant link between
elevated faecal haemoglobin levels and an increased risk of colorectal
neoplasia.
10 Dec 2024


OBESITY LINKED TO IMPROVED SURVIVAL IN CANCER PATIENTS TREATED WITH CELL THERAPY

This retrospective multicohort analysis, examined 95 patients who received ACT
across various clinical trials from 2017 to 2023…


8 Dec 2024


AI-POWERED LIQUID BIOPSY TEST SHOWS BREAKTHROUGH IN CANCER DETECTION

A groundbreaking study has demonstrated that AI-driven liquid biopsies could
revolutionise cancer care…
6 Dec 2024


EXTENDED COLONOSCOPY RESCREENING FOR LOW-RISK INDIVIDUALS

The research aimed to assess the long-term risk of CRC based on colonoscopy
screening results and demographic and lifestyle risk factors…

4 Dec 2024


LUNG CANCER SCREENING BENEFITS LIMITED FOR SMOKERS WITH SEVERE AIRFLOW
LIMITATION

The study followed 18,463 high-risk smokers, who underwent pre-bronchodilator
spirometry tests and were tracked over a median period of 6.1 years.
3 Dec 2024


NEW DISCOVERY REVEALS VITAMIN B6'S POTENTIAL IN TARGETING CANCER CELLS

A groundbreaking study has identified a naturally occurring ligand derived from
vitamin B6 that can activate immune cells to target tumours…


2 Dec 2024


CHRONIC PAIN LINKED TO CEREBROVASCULAR DISEASE DEATHS IN PATIENTS WITH CANCER

A recent study has explored the relationship between chronic pain and the risk
of death from cerebrovascular disease in cancer patients…
30 Nov 2024


COMBINATION TREATMENT SHOWS PROMISE FOR ADVANCED LUNG CANCER

A new study has explored the effectiveness of combining transpulmonary
chemoembolisation and microwave ablation for treating non-small cell lung
cancer…

29 Nov 2024


STUDY REVEALS MELANOMA TRENDS IN CHILDREN AND YOUNG ADULTS

A recent study has provided new insights into melanoma incidence and
presentations among paediatric and adolescent and young adult patients.
28 Nov 2024


NO SURVIVAL BENEFIT FOR CHEMORADIOTHERAPY IN OESOPHAGEAL CANCER

A new study comparing treatment strategies for stage T2N0M0 oesophageal cancer
has revealed no significant survival advantage for patients receiving
neoadjuvant chemoradiotherapy followed by surgery.


26 Nov 2024


HALF OF EARLY-ONSET CANCER PATIENTS MISS FERTILITY PRESERVATION DISCUSSIONS

A recent study from the REACT initiative highlights a significant gap in
fertility preservation discussions for early-onset cancer patients, with nearly
half reporting that they were not informed about fertility options before
beginning treatment.
24 Nov 2024


BORON NEUTRON CAPTURE ENHANCED PROTON THERAPY SHOWS INCREASED CELL KILLING
EFFECT

A new study reveals that combining proton beam therapy with boron neutron
capture reactions increases its cell-killing effect, with higher boron
concentrations yielding stronger therapeutic results…

22 Nov 2024


RESTAGING MRI PREDICTS OUTCOMES IN LOCALLY ADVANCED RECTAL CANCER AFTER
NEOADJUVANT THERAPY

Restaging MRI is a powerful tool for predicting survival and organ preservation
in rectal cancer patients after total neoadjuvant therapy…
20 Nov 2024


INDUCTION CHEMOTHERAPY IMPROVES SURVIVAL IN LOCALLY ADVANCED CERVICAL CANCER

A new phase 3 trial (INTERLACE) shows that adding induction chemotherapy to
standard chemoradiotherapy improves both progression-free and overall survival
in patients with locally advanced cervical cancer.


18 Nov 2024


NEW STUDY SHEDS LIGHT ON POTENTIAL TREATMENT TARGET FOR NEUROBLASTOMA

A new study reveals how the m6A epitranscriptomic modification and MYCN oncogene
cooperate to maintain an undifferentiated state in neuroblastoma…
16 Nov 2024


NEW APPROACH OFFERS HOPE FOR DRUG-RESISTANT LUNG CANCER

Researchers have developed a novel treatment for non-small cell lung cancer
(NSCLC) that uses customised antisense oligonucleotides (ASOs) to selectively
target drug-resistant EGFR mutations.

14 Nov 2024


THREE-CYCLE CHEMOTHERAPY PROVES EFFECTIVE FOR HIGH-RISK RETINOBLASTOMA

A recent trial found that three cycles of CEV chemotherapy are as effective as
six in treating high-risk unilateral retinoblastoma after enucleation.
12 Nov 2024


STUDY IDENTIFIES GENETIC VULNERABILITIES OF GLIOBLASTOMA

A recent study uncovers genetic vulnerabilities in glioblastoma stem cells,
pinpointing subtype-specific dependencies that drive tumour growth.


10 Nov 2024


INCREASED HEALTH RISKS FOR FAMILY MEMBERS OF CANCER PATIENTS

A recent study reveals that family members of cancer patients are at greater
risk for developing psychological illnesses and cardiovascular diseases. The
research highlights the need for better healthcare support for families coping
with cancer.
8 Nov 2024


NO SURVIVAL BENEFIT OF EXTENDED LYMPHADENECTOMY IN BLADDER CANCER SURGERY

A new clinical trial has found that extended lymphadenectomy does not improve
disease-free or overall survival rates compared to standard lymphadenectomy in
patients with localized muscle-invasive bladder cancer.

6 Nov 2024


HEALTH INSURANCE IMPACT ON CANCER DISPARITIES AMONG RACIAL AND ETHNIC GROUPS

A recent analysis of the National Cancer Database reveals that health insurance
plays a crucial role in racial and ethnic disparities in late-stage cancer
diagnoses.
4 Nov 2024


SOCIOECONOMIC FACTORS IMPACT PROSTATE CANCER TESTING PARTICIPATION

Socioeconomic factors influence prostate cancer test participation, with lower
income and education linked to reduced uptake in organised screening programs.


Loading posts...
« Previous 1 2 3 4 5 … 42 Next »


ELEVATING THE QUALITY OF HEALTHCARE GLOBALLY


ELEVATING THE QUALITY OF HEALTHCARE GLOBALLY




THERAPY AREA

 * Allergy & Immunology
 * Cardiology
 * Dermatology
 * Diabetes
 * Flagship Journal
 * Gastroenterology
 * General Healthcare
 * Hematology
 * Hepatology
 * Innovations
 * Interventional Cardiology
 * Nephrology
 * Neurology
 * Oncology
 * Reproductive Health
 * Respiratory
 * Rheumatology
 * Urology


ABOUT US

 * About Us
 * EMJ GOLD
 * Podcast: Gold with Gore
 * Careers
 * Partners & Directory
 * Compliance
 * Open Access & Copyright
 * Contact Us
 * Events
 * Contributors
 * Subscribe to our email newsletter
 * Media Pack
 * The New World of EMJ
 * FAQ
 * Editorial Policy
 * Quality Policy
 * Journals
 * Editorial Enquiries
 * Our Pharma Partners
 * EMJ & American Medical Journal’s Mission to Elevate the Quality of Healthcare
   Globally
 * EQOH Scoring
 * EMJ Interactive Content
 * Interactive Content

 * 
 * 
 * 
 * 

This site is intended for healthcare professionals.

Copyright © 2024 European Medical Group LTD trading as European Medical Journal.
All rights reserved. European Medical Journal is for informational purposes and
should not be considered medical advice, diagnosis or treatment recommendations.

Ts & Cs Privacy Policy Cookie Policy

Website by Vibe Agency
 * 
 * 
 * 
 *